Development of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials.
about
Translation and validation of non-English versions of the Ankylosing Spondylitis Quality of Life (ASQOL) questionnaireQuality of life in patients with psoriasisTopical treatments for chronic plaque psoriasisTNF-alpha inhibitors for psoriatic arthritisTopical treatments for chronic plaque psoriasisDevelopment of the PsAQoL: a quality of life instrument specific to psoriatic arthritisPsoriasis: epidemiology, clinical features, and quality of lifeDevelopment and psychometric validation of the REFlective evaLuation of psoriasis Efficacy of Treatment and Severity (REFLETS) questionnaire: a common measure of plaque-type psoriasis severity and treatment efficacy for patients and clinicians.Psoriatic arthritis assessment tools in clinical trials.Translation, cross-cultural adaptation and validation of the vitiligo-specific health-related quality of life instrument (VitiQoL) into Brazilian PortugueseWhat should undergraduate medical students know about psoriasis? Involving patients in curriculum development: modified Delphi technique.Current severe psoriasis and the rule of tens.Two decades experience of the Psoriasis Disability Index.Validation of a new tool to assess health-related quality of life in psoriasis: the PSO-LIFE questionnaire.Reliability and validity of the Chinese version of the Psoriasis Disability Index (PDI) in Chinese patients with psoriasisTeledermatology research review.Epidemiology of psoriasis. Review and the German perspective.The Polish version of Skindex-29: psychometric properties of an instrument to measure quality of life in dermatology.Assessing adherence factors in patients under topical treatment: development of the Topical Therapy Adherence Questionnaire (TTAQ).Measurement of health-related quality of life in dermatological research and practice: outcome of the EADV Taskforce on Quality of Life.Topical treatments for chronic plaque psoriasis of the scalp: a systematic review.Patient-reported outcome measures in psoriasis: the good, the bad and the missing!Living with skin diseases and topical treatment: patients' and providers' perspectives and priorities.Psoriasis and psoriatic arthritis in African-American patients--the need to measure disease burden.Quality of life in infants and children with atopic dermatitis: addressing issues of differential item functioning across countries in multinational clinical trialsPsychometric properties of the Chinese version of Dermatology Life Quality Index (DLQI) in 851 Chinese patients with psoriasis.Results of the validation study of the Psodisk instrument, and determination of the cut-off scores for varying degrees of impairment.The impact of biologic agents on health-related quality of life outcomes in patients with psoriasis.Comparing the impact of psoriasis and atopic dermatitis on quality of life: co-calibration of the PSORIQoL and QoLIAD.The Rheumatoid Arthritis Quality of Life (RAQoL) for Sweden: adaptation and validation.Refinement and reduction of the Impact of Psoriasis Questionnaire: classical test theory vs. Rasch analysis.Clinical management decisions are related to the impact of psoriasis on patient-rated quality of life.General measures and quality of life issues in psoriasis.The Pathophysiological Mechanisms and the Quest for Biomarkers in Psoriasis, a Stress-Related Skin Disease.
P2860
Q21245615-0F2FBA25-1ADA-436A-AFDD-E0C385E7F99FQ21245617-4CFEB60F-B2E4-4560-9D52-0C77B409077AQ24198258-9F265039-A570-458E-B078-AC842122B567Q24240905-E7C7947E-A94F-4BFD-9E30-175A28F25BE3Q24241239-9B885734-AC8B-46E8-9800-F175138E7F5EQ24673687-E49A4EB0-62CD-44C7-843C-42B470537DDEQ24675003-A53F5D0D-26B4-4B4D-B09E-39843F8C84B8Q35175365-A9D7BCFA-DB87-4E7C-8D4B-466A86DE0D12Q35579462-97B867AE-2AA2-4E1B-AD5A-C9729F03597FQ35892146-AF8B06CD-3D69-4850-9571-3340AB9B2B3AQ36073454-7EFAC7AE-2400-4BD5-9FE6-3BC1B7AB3D66Q36124195-4BEAF232-7731-47B3-9407-D398B6EFA409Q36155048-B9BAB37A-721C-41F1-875F-5E17C2525337Q36281548-BB81DC50-CF80-4953-8CF6-D9D6654048BEQ36299430-2474A6E4-21ED-4E56-B33B-0DF63C495C40Q36419688-85EE8BDC-A645-48D8-846F-28533A07EF90Q36481432-D568FF1A-669E-452A-9885-7E074F7128A5Q37634322-5F60A6C2-06E9-4D23-8D9F-1239AA5C7899Q37638892-885698B8-7BFD-4627-9267-A9206AE0F885Q38072725-BECE0AA1-043D-4AED-8747-0D0ECF437C7FQ38116596-D5B5DEBE-56D6-4BFA-886B-912518E0665BQ38354062-7A79ACCF-0BE6-4BE9-8ED3-06DC10EF57FEQ40187313-4F1F4A05-2812-42A0-91B4-2A2F9CD372C6Q40218228-F7FDF0D9-4C6E-44C6-82B6-61ECD21A87FBQ41373800-63C1D23B-7CFE-49E4-BFEC-54AF48A8E05EQ43866712-D3D29807-E82E-4EDB-8C9F-6C23A5704F56Q44972145-10A1E3D9-A944-4C3F-B311-A6A7226D73D5Q47644680-66D31225-4F0F-4E09-95DC-6DBE7C1DF8AFQ48087641-39ACB9C7-AAEF-4C43-840C-32CBB54830F3Q51808394-E9900085-C25D-4E4A-97EC-C1A347F46B49Q51920393-2B628EA4-2915-4675-BC4D-B1664DFAA7A6Q53581782-F2285422-C1DB-4042-BB22-52252387975AQ53728309-64A7F766-69A7-48BE-9102-A316E4B63EEAQ54956609-08B4D384-10C6-4ADB-B511-BCB60C43CFCD
P2860
Development of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Development of the PSORIQoL, a ...... clinical practice and trials.
@ast
Development of the PSORIQoL, a ...... clinical practice and trials.
@en
Development of the PSORIQoL, a ...... clinical practice and trials.
@nl
type
label
Development of the PSORIQoL, a ...... clinical practice and trials.
@ast
Development of the PSORIQoL, a ...... clinical practice and trials.
@en
Development of the PSORIQoL, a ...... clinical practice and trials.
@nl
prefLabel
Development of the PSORIQoL, a ...... clinical practice and trials.
@ast
Development of the PSORIQoL, a ...... clinical practice and trials.
@en
Development of the PSORIQoL, a ...... clinical practice and trials.
@nl
P2093
P2860
P1476
Development of the PSORIQoL, a ...... clinical practice and trials.
@en
P2093
Griffiths CE
McKenna SP
Richards HL
Van Assche D
P2860
P304
P356
10.1046/J.1365-2133.2003.05492.X
P407
P577
2003-08-01T00:00:00Z